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 ABSTRACT: D12-Prostaglandin J family is recently discov-
ered and has potent anti-cancer activity.  Concise syntheses 
of four D12-prostaglandin J natural products (7–8 steps in the 
longest linear sequences) are reported, enabled by conver-
gent stereoretentive cross-metathesis.  Exceptional control of 
alkene geometry was achieved through stereoretention.  
    Prostaglandins are an important class of naturally occur-
ring molecules that are found in mammalian tissues and ex-
hibit a broad range of biological functions and widespread 
medical applications.1  Efforts directed toward the synthesis 
of various prostaglandins has had a profound effect on the 
development of new strategies and tactics employed in the 
field of synthetic chemistry, emanating from the seminal 
studies of Corey beginning in the 1960’s.2  The recently dis-
covered D12-prostaglandin J family (1–4, Scheme 1) features 
a unique cross-conjugated dienone motif and appealing anti-
cancer activity.3  D12-PGJ3 (3), for example, was isolated as a 
secondary metabolite and was shown to selectively induce 
apoptosis of leukemia stem cells over normal hematopoietic 
stems cells with high potency.4  Studies of its stability, bioa-
vailability, and hypersensitivity make D12-PGJ3 an intriguing 
drug candidate for leukemia treatment.5  Synthetic efforts 
toward D12-prostaglandin J compounds began in 2003, with a 
number of syntheses of D12-PGJ2 (1) and 15d-PGJ2 (2) re-
ported through various approaches.6  Elegant contributions 
to the total synthesis of D12-PGJ3 (3) were reported by Nico-
laou and co-workers7 and more recently by the Aggarwal 
group.8  A number of D12-PGJ3 analogues were also accessi-
ble via a streamlined synthesis developed by Nicolaou and 
co-workers 9  to enable a comprehensive structural-activity 
relationship (SAR) study of their anti-cancer activities.  
Olefin cross-metathesis is a convergent method for build-
ing C–C double bonds in natural product syntheses;10 how-
ever, it has seldom been applied in the previous syntheses of 
D12-PGJ family.  Most importantly, conventional metathesis 
catalysts typically gave imperfect control of alkene geometry.  
Previous syntheses relied on the semi-hydrogenation of al-
kynes or Wittig reactions, requiring multi-step functional  
Scheme 1. D12-Prostaglandin J Natural Products and Retro-
synthetic Analysis  
group manipulation with concomitant waste generation.  
From a strategic perspective, chemoselectivity among multi-
ple alkenes has also been another concern, especially in the 
later stages.  Stereoselective and alkene-chemoselective me-
tathesis catalysts are in demand to realize a convergent syn-
thesis from simple alkene building blocks.   
A series of cyclometallated ruthenium-based catalysts (e.g. 
Ru-1, Ru-2, Figure 1) were recently developed by Grubbs 
and co-workers, 11  and enabled Z-selective metathesis 
through a favored syn-metallacyclobutane intermediate 
(Figure 1, Path A).  More recently, catechodithiolate-based 
catalyst Ru-3 and its dithiolate variants were developed by 
Hoveyda group and showed high Z-selectivity in ring-
opening metathesis polymerizations, ring-opening cross-
metathesis, and cross-metathesis with Z-olefins.12  In fact, 
high kinetic E-selectivity in cross-metathesis with E-starting 
materials was also observed with Ru-3, the sIPr analogue Ru-
4, and other less bulky fast-initiating analogues developed by 
Materia Inc. and the Grubbs group,13 that defined these cata-
lysts as stereoretentive.  The origin of the stereoretention  
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  Figure 1. Z-selective and Stereoretentive Metathesis Catalysts 
and Models of Their Stereoselectivity 
 
was attributed to the formation of a side-bound metallacy-
clobutane intermediate, of which the a-substituents are 
forced down to minimize steric interactions with the bulky 
N-aryl groups of the NHC.  As a result, when starting with Z-
alkenes, the b-substituent points down to generate Z-alkene 
products (Figure 1, Path B).  When starting with E-alkenes, 
however, the b-substituent has to point up into the open 
space between two N-aryl groups, leading to the generation 
of E-alkene products, albeit with slower rates (Figure 1, Path 
C).  Cross-metathesis between two terminal alkenes is not 
possible with stereoretentive metathesis catalysts, however, 
because the intermediate methylidene species are unstable 
and lead to catalyst decomposition.12d  A methylene capping 
strategy was recently reported as a remedy to this problem, 
enabling the cross-metathesis of two terminal alkenes.14   
    Despite the unique properties of these stereoretentive cata-
lysts, to date, limited synthetic evaluation of these catalysts 
has been conducted.15  Herein, we present a total synthesis of 
the olefin-enriched D12-prostaglandin J natural products 1–4 
by implementing a concise stereoretentive metathesis ap-
proach.  This also sets a perfect test ground to evaluate the 
reactivity, chemoselectivity, and functional group compati-
bility of these newly developed metathesis catalysts. 
    Retrosynthetically, D12-PGJ3 (3) for example can be simpli-
fied into a truncated prostaglandin structure 22 by use of 
stereoretentive metathesis (Scheme 1).  A three-component 
coupling strategy16 can be applied toward the synthesis of 22, 
using a relatively simple and commercially available allyl Gri-
gnard reagent, w-chain aldehyde 21, and a chiral cyclopente-
none (R)-6.  The O-Boc group of (R)-6 can be used as a 
traceless stereoinductive group to set the C8 stereocenter.17  
    We initially aimed to synthesize D12-PGJ2 (1).  Chiral cy-
clopentenone (R)-6 was prepared from furfuryl alcohol in a 
three-step process including a kinetic resolution method 
developed by Reiser and coworkers (Scheme 2A).18  The w-
chain aldehyde 10 was prepared from hexanal (7) through 
asymmetric Keck allylation,19  TBS protection, and ozonoly-
sis (Scheme 2B).  With all the starting materials for the three-
component coupling in hand, CuBr•Me2S and LiCl facilitat-
ed the diastereoselective conjugate addition of the allyl mag-
nesium bromide.  The enolate formed can then be trapped 
by the subsequently added w-chain aldehyde electrophile, 
and the O-Boc group was eliminated in the course of the 
aldol reaction to form the desired cyclopentenone.  Elimina-
tion with MsCl and DMAP favored 12E-product 11 as the 
major product in reasonable yield (45% over 2 steps, Scheme 
2D).  
    Stereoretentive metathesis was then evaluated on 11.  
Since 11 cannot react with another terminal alkene using 
stereoretentive metathesis catalysts, we considered a sym-
metric Z-alkene 13 as the coupling partner, which could also 
be made by homodimerization of readily available 12 
through stereoretentive metathesis.  With 1 mol% loading of 
Ru-4 as the catalyst, 98% conversion could be achieved by 
applying dynamic vacuum to remove the by-product, cis-3-
hexene (bp 66–68 ºC) from the reaction mixture.  Next, 11 
with an additional 5 mol% catalyst Ru-4 were added into the 
reaction mixture, and the alcohol product 14 could be isolat-
ed in 95% yield in high Z-selectivity (>99% Z).  This result 
established the efficacy of an efficient one-pot, stereoreten-
tive homodimerization/cross-metathesis strategy to build 
the C5 Z-alkene.  In contrast, synthesis of PGE2 and PGF2a 
required a large excess of gaseous butene and more compli-
cated operations in the previously reported methylene cap-
ping strategy.14  Ley oxidation and deprotection of the TBS 
group of 14 in aqueous HF furnished the natural product 
D12-prostaglandin J2 (1) in 89% yield over the last two steps. 
The same three-component coupling sequence was per-
formed to obtain 16, and the enal functionality of aldehyde 
15 was well tolerated in the aldol step.  16 was then subjected 
to the standard one-pot stereoretentive homodimeriza-
tion/cross-metathesis conditions, and alcohol 17 was ob-
tained in excellent yield (93% yield, Scheme 2D) with high 
Z-selectivity (>99% Z).  The C14 E-alkene tolerated the 
reaction, consistent with the much slower reaction of E-
alkenes with Ru-4 as seen previously.13  We also assessed the 
enantiopurity of intermediates 16 and 17.  Three-component 
coupling product 16 proceeded with a small loss in enanti-
opurity (88% ee) from (R)-6 (>99% ee), but the metathesis 
product 17 was obtained without significant erosion of enan-
tiopurity (87% ee).  This result demonstrates that stereore-
tentive metathesis with catalyst Ru-4 also retained the stere-
ochemistry of the C8 stereocenter.  Ley oxidation of 17 again 
gave 15-deoxy-D12,14-prostaglandin J2 (2) in 68% yield. 
Synthesis of D12-prostaglandin J3 (3) began with the prepa-
ration of the w-chain aldehyde 21.  We envisioned the Z-
alkene in 21 could also be generated from stereoretentive 
metathesis.  First, we obtained chiral alcohol 18 through a  
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 Scheme 2. Synthetic Route to D12-PGJ Natural Products 
reported chiral pool strategy with (R)-epichlorohydrin as the 
starting material (Scheme 2C).20  TBS protection of the al-
cohol and subsequent removal of the 1,3-dithiol gave alde-
hyde 20.  Stereoretentive metathesis of 20 with an excess 
amount of cis-3-hexene using catalyst Ru-4 (4 mol%) afford-
ed w-chain aldehyde 21 in good yield (88%) with high Z-
selectivity (>99% Z).  The short synthesis of aldehyde 21 
proved that a broad range of functional groups, including 
aldehydes, can be tolerated without protecting group manip-
ulations using stereoretentive catalysts.  Then, 22 was syn-
thesized through the standard three-component coupling 
sequence from (R)-6 (Scheme 2D).  Surprisingly, fast ring-
closing metathesis (RCM) with Ru-4 yielded 24 as a by-
product (31% yield) bearing an unusual 9-membered ring,  
 
 
and the desired alcohol product 23 was obtained in only 44% 
yield.   
Alternatively, we chose to use cyclometallated catalyst Ru-
2 to circumvent the crossover of alkene reactivity.  Because 
tri-substituted metallacyclobutane intermediates are highly 
unfavorable with this cyclometallated catalyst, this pathway 
can be easily avoided (Scheme 2E).21  Chemoselective cross-
metathesis of 5-hexen-1-ol (25) with the allyl group of 22 
furnished the desired product 23 in good yield (52%) with a 
trace amount of by-product 26 (less than 2%, Scheme 2F).  
The RCM product 24 was not observed under these condi-
tions.  The side-reaction of C17 internal Z-alkene could be 
attributed to ethylene produced or the residual ruthenium 
methylidene species in the solution.  Then, Ley oxidation of 
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 23 and deprotection of the TBS group with aqueous HF pro-
vided D12-prostaglandin J3 (3) in 8 linear steps.  
     Finally, in the synthesis of 15d-PGJ3 (4), crossover of me-
tathesis reactivity between the allyl group and the C17 Z-
alkene of 28 could also be expected.  Standard stereoreten-
tive metathesis conditions with Ru-4 provided desired prod-
uct 29 in 36% yield and by-products 30 and 31 (Scheme 
2F).22  Compared to D12-PGJ3 (3) synthesis, where the steric 
bulk of the OTBS group may be beneficial to achieving good 
chemoselectivity, 28 has no such steric hindrance.  However, 
no RCM of 28 was observed, possibly due to the ring strain 
of RCM product.  Though 30 could not be separated from 
29, the mixture was subjected to PCC oxidation and Pinnick 
oxidation conditions23, allowing us to isolate 15-deoxy-D12,14-
prostaglandin J3 (4) (12% yield from 28). 
       In conclusion, we report a concise and convergent syn-
thesis of four D12-prostaglandin J natural products in shorter 
sequences (7–8 steps in the longest linear sequences) em-
powered by stereoretentive and stereoselective metathesis.  
Furthermore, the reactivity, chemoselectivity, and functional 
group compatibility of stereoretentive metathesis was evalu-
ated.  This study should inspire further practical applications 
of stereoselective metathesis, such as a facile one-pot stere-
oretentive homodimerization/cross-metathesis strategy to 
introduce Z-alkenes with excellent geometric control.  The 
modularity and expediency of this chemistry opens the syn-
thesis of other prostaglandins and analogues to enable SAR 
studies in cancer treatment.  With the well-defined kinetical-
ly Z/E-selective catalysts that have been developed to over-
come the inherent thermodynamic preference of alkene 
product geometry, olefin metathesis can play a pivotal role in 
the synthesis design. 
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